Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OncoArendi Therapeutics SA (DE:1B1)
FRANKFURT:1B1
OncoArendi Therapeutics SA (1B1) Stock Price & Analysis
0 Followers
1B1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€3.22 - €5.35
Previous Close€3.38
Volume0.00
Average Volume (3M)N/A
Market Cap
€58.74M
Enterprise Value€44.93M
Total Cash (Recent Filing)zł65.62M
Total Debt (Recent Filing)zł6.41M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Sep 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,836,000
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
OncoArendi Therapeutics SA News
1B1 FAQ
What was OncoArendi Therapeutics SA’s price range in the past 12 months?
OncoArendi Therapeutics SA lowest stock price was €3.21 and its highest was €5.35 in the past 12 months.
What is OncoArendi Therapeutics SA’s market cap?
Currently, no data Available
When is OncoArendi Therapeutics SA’s upcoming earnings report date?
OncoArendi Therapeutics SA’s upcoming earnings report date is Sep 27, 2024 which is in 118 days.
How were OncoArendi Therapeutics SA’s earnings last quarter?
Currently, no data Available
Is OncoArendi Therapeutics SA overvalued?
According to Wall Street analysts OncoArendi Therapeutics SA’s price is currently Overvalued.
Does OncoArendi Therapeutics SA pay dividends?
OncoArendi Therapeutics SA does not currently pay dividends.
What is OncoArendi Therapeutics SA’s EPS estimate?
OncoArendi Therapeutics SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoArendi Therapeutics SA have?
Currently, no data Available
What happened to OncoArendi Therapeutics SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of OncoArendi Therapeutics SA?
Currently, no hedge funds are holding shares in DE:1B1
---
OncoArendi Therapeutics SA Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
OncoArendi Therapeutics SA
Oncoarendi Therapeutics SA is a biopharmaceutical company engaged in discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
---
Technical Analysis
---